IMS Solutions is a company developing diagnostic solutions using advanced mass spectrometry and machine learning. Our technology analyses steroid metabolites to identify unique chemical signatures associated with conditions such as adrenocortical cancer, with the aim of allowing faster and more accurate diagnosis. Further product opportunities exist for our data-driven machine learning algorithms in women’s health, particularly in the stratification of patients identified with PMOS (polyendocrine metabolic ovary syndrome) enabling improved management and treatment options for the condition.
IMS Solutions: Venture Capital Funding History
IMS Solutions
IMS Solutions
- Health
- Birmingham, United Kingdom
- £1.1m
- intelligentmassspec.com
- Update Information
More venture news
- 5 Nov 2026

NayaraNayara closes a pre-seed round led by SFC Capital to support patients between appointments with AI companions
Pre-seedHealth - 4 Nov 2026

SurghiveSurghive raises a £320k seed round led by SFC Capital to train surgeons on any robotic surgery system
SeedHealth - 3 Nov 2026

1nhaler1nhaler lands a £2m follow-on round led by Archangels to test its pop-up cardboard asthma inhaler in patients
Follow-onHealth
